Cargando…
Mandatory requirements for pediatric drug development in the EU and the US for novel drugs—A comparative study
Mandatory pediatric legislation has been implemented in the European Union (EU) and the United States (US) to increase research and the availability of drugs for the pediatric population. Differences in the legislative framework can cause different pediatric requirements for similar indications gran...
Autores principales: | Christiansen, Helle, De Bruin, Marie L., Hallgreen, Christine E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659631/ https://www.ncbi.nlm.nih.gov/pubmed/36388912 http://dx.doi.org/10.3389/fmed.2022.1009432 |
Ejemplares similares
-
Guidance for pediatric use in prescription information for novel medicinal products in the EU and the US
por: Christiansen, Helle, et al.
Publicado: (2022) -
Improving Interactions Between Health Technology Assessment Bodies and Regulatory Agencies: A Systematic Review and Cross-Sectional Survey on Processes, Progress, Outcomes, and Challenges
por: Ofori-Asenso, Richard, et al.
Publicado: (2020) -
Status of Planned and Ongoing Paediatric Trials Investigating COVID-19 Vaccines: A Cross-Sectional Study of Paediatric Clinical Trials Planned in Agreed PIPs and/or Registered in Clinical Trial Databases
por: Christiansen, Helle, et al.
Publicado: (2022) -
The role of globalization in drug development and access to orphan drugs: orphan drug legislation in the US/EU and in Latin America
por: Arnold, Renée J.G., et al.
Publicado: (2015) -
US, EU, and Japanese Regulatory Guidelines for Development of Drugs for Treatment of Alzheimer’s Disease: Implications for Global Drug Development
por: Morant, Anne Vinther, et al.
Publicado: (2020)